Radiotherapy Combined With PD-1 Inhibitor and GM-CSF for Advanced Recurrent Metastatic Head and Neck Tumors
Status:
Recruiting
Trial end date:
2025-09-30
Target enrollment:
Participant gender:
Summary
This is an intervention study, aiming to use high and low dose radiotherapy combined with
PD-1/PD-L1 inhibitor combined with GM-CSF to observe the effect of anti-tumor immunity and
long-term therapeutic response rate, and to explore a new treatment model for patients with
advanced solid tumors.